No abstract available
Keywords:
11q; Burkitt lymphoma; PTLD; post-transplant lymphoproliferative disease.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
1-Alkyl-2-acetylglycerophosphocholine Esterase / genetics
-
1-Alkyl-2-acetylglycerophosphocholine Esterase / metabolism
-
Adolescent
-
Adult
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols*
-
B-Lymphocytes / metabolism
-
B-Lymphocytes / pathology
-
Burkitt Lymphoma / drug therapy
-
Burkitt Lymphoma / etiology
-
Burkitt Lymphoma / genetics*
-
Burkitt Lymphoma / mortality
-
Chromosomes, Human, Pair 11
-
Cyclophosphamide
-
Doxorubicin
-
Epstein-Barr Virus Infections / drug therapy
-
Epstein-Barr Virus Infections / etiology
-
Epstein-Barr Virus Infections / genetics*
-
Epstein-Barr Virus Infections / mortality
-
Gene Expression Regulation, Neoplastic*
-
Gene Regulatory Networks
-
Heart Transplantation / adverse effects
-
Humans
-
Immunosuppression Therapy / adverse effects
-
Kidney Transplantation / adverse effects
-
Liver Transplantation / adverse effects
-
Male
-
Microtubule-Associated Proteins / genetics
-
Microtubule-Associated Proteins / metabolism
-
Middle Aged
-
Mutation
-
Prednisone
-
Proto-Oncogene Protein c-ets-1 / genetics
-
Proto-Oncogene Protein c-ets-1 / metabolism
-
Proto-Oncogene Protein c-fli-1 / genetics
-
Proto-Oncogene Protein c-fli-1 / metabolism
-
Proto-Oncogene Proteins c-myc / genetics
-
Rituximab / therapeutic use
-
Signal Transduction
-
Survival Analysis
-
Translocation, Genetic*
-
Vincristine
Substances
-
ETS1 protein, human
-
FLI1 protein, human
-
MYC protein, human
-
Microtubule-Associated Proteins
-
Proto-Oncogene Protein c-ets-1
-
Proto-Oncogene Protein c-fli-1
-
Proto-Oncogene Proteins c-myc
-
Rituximab
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
1-Alkyl-2-acetylglycerophosphocholine Esterase
-
PAFAH1B2 protein, human
-
Prednisone